faculty scholarship BLOG 

West Virginia College of Law professor S. Sean Tu published new scholarship in the New England Journal of Medicine. The article, titled "Product Hopping in the Drug Industry — Lessons from Albuterol" is co-authored by Professor Tu, Olivier J. Wouters, Ph.D. of the London School of Economics and Political Science, and William B. Feldman, M.D., D.Phil., M.P.H. of Brigham and Women’s Hospital and Harvard Medical School.  It was published online by the journal on September 24, 2022 and will subsequently appear in print on September 29, 2022.

Find more of Professor Tu's scholarship on SSRN.

This week, West Virginia College of Law professor Sean Tu published an op-ed in the Los Angeles Times with co-authors Michael A. Carrier and Charles Duan. The op-ed, titled "Prevent a legal catch-22 that could push thousands of generic drugs off the market" appeared on September 21, 2022 and follows the filing of an amicus curiae brief by the authors in Teva Pharmaceuticals v. GlaxoSmithKline, No. 22-37. The United States Supreme Court will hear arguments in the case this forthcoming Ocobter 2022 term.

A summary of Brief of 42 Professors of Law, Economics, Business, and Medicine as Amici Curiae in Support of the Petition follows:

West Virginia University College of Law professor Sean Tu published a new article in Health Affairs Forefront on June 21, 2022. Professor Tu, with co-authors Dennis Crouch of the University of Missouri and Aaron Kesselheim of Harvard University, makes a proposal to change the panent approval and patent examination process. The proposal targets "high-reference patents" or those that are submitted with hundreds of citations by the applicants.

Professor Tu's article may be found online: https://www.healthaffairs.org/do/10.1377/forefront.20220615.404330